Stay updated on Nivolumab in Salivary Gland Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Salivary Gland Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Salivary Gland Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No substantive study data or page content appears to be altered.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision: v3.4.3 has been added and Revision: v3.4.2 has been removed, updating the page’s version label.SummaryDifference0.1%

- Check53 days agoChange DetectedA new system revision v3.4.2 was added, and the earlier revision v3.4.1 along with the notice about government funding status was removed. These updates do not affect the study details, eligibility criteria, or user-facing content.SummaryDifference0.4%

- Check60 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center being open (with links to cc.nih.gov and opm.gov) was added, and the page revision was updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedThe update adds a glossary toggle, updates the QC criteria label, adjusts the No FEAR Act data text, and changes the revision tag from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision: v3.3.4 has been added and v3.3.3 removed. No study content or results appear affected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Salivary Gland Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Salivary Gland Carcinoma Clinical Trial page.